Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA
NCT06091098 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2025-03-19
Summary
Obstructive sleep apnea (OSA) is a highly prevalent disorder that has major consequences for cardiovascular health, neurocognitive function, risk of traffic accidents, daytime sleepiness, and quality of life. For years, a "classic" model of OSA has been used to describe the disorder, which fails to capture it's complexity. Recently, a model for OSA called drive-dependent OSA was discovered be more prevalent in the OSA population. The drive-dependent subgroup benefits exclusively from increased ventilation, increased dilator muscle activity, and reduced event risk when drive spontaneously rises. This study seeks to provide direct evidence that reducing the loss of drive prevents the loss of ventilation, pharyngeal muscle activity, and thus the onset of OSA respiratory events, specifically in "drive-dependent" but not "classic" OSA. This will be achieved using CO2 delivered at precise times during breaths in sleep to prevent loss of overall ventilatory drive.
Conditions
- OSA
Interventions
- OTHER
-
Dynamic CO2
2% inspired CO2 for 2-4 breaths
- OTHER
-
Sham CO2
Air
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
Scott Sands, PhD · Brigham and Women's Hospital and Harvard Medical School
-
Dillon Gilbertson · Brigham and Women's Hospital and Harvard Medical School
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-27
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
NCT05237505 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease
NCT02059993 ·Status: COMPLETED ·Phase: NA
-
Effects of Exercise Training on Cognitive Performance and Sympathetic Activity in Obstructive Sleep Apnea
NCT02289625 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study A
NCT01728974 ·Status: COMPLETED ·Phase: NA
-
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010 ·Status: COMPLETED ·Phase: PHASE4
-
Potential Mechanism of Exercise Impairment in OSA
NCT02505594 ·Status: COMPLETED
-
The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea
NCT00701441 ·Status: COMPLETED
-
Sleep Apnea Intervention for Cardiovascular Disease Reduction
NCT01261390 ·Status: COMPLETED ·Phase: NA
-
Acetazolamide on REM OSA
NCT05589792 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oxytocin on HR in Sleep Apnea Patient
NCT02564068 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Remifentanil in Adults With OSA
NCT02898792 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of CPAP on Diet, Physical Activity, and Cardiovascular Risk
NCT01944020 ·Status: COMPLETED ·Phase: NA
-
Validation of a New Automatic Bi-level Algorithm in the Treatment of Sleep-disordered Breathing
NCT00910195 ·Status: COMPLETED ·Phase: NA
-
Novel physIologiC prEdictors of Positive Airway Pressure Effectiveness
NCT05067088 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep
NCT03148899 ·Status: COMPLETED ·Phase: PHASE2
-
Autonomic Function in Obstructive Sleep Apnea
NCT00681161 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients
NCT00741520 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C
NCT01738022 ·Status: WITHDRAWN ·Phase: NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
NCT05558501 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
NCT00607893 ·Status: COMPLETED ·Phase: NA
-
Atomoxetine and Oxybutynin in Obstructive Sleep Apnea
NCT02908529 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Obstructive Sleep Apnea on Central Blood Pressure and Kidney and Endothelial Function
NCT00947479 ·Status: UNKNOWN ·Phase: NA
-
Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea
NCT04639193 ·Status: COMPLETED ·Phase: PHASE2
-
Sleep Apnea, Cardiovascular and Exercise Study
NCT03219749 ·Status: COMPLETED ·Phase: NA
-
DAW1033B2 in Obstructive Sleep Apnea
NCT03426631 ·Status: COMPLETED ·Phase: PHASE1/PHASE2